[Panel II] Corporate Strategy for a Changing International System
Fundamental challenges to past assumptions on politics and markets pose threats for international businesses. But there may also be rewards for those who successfully navigate growing uncertainty. In a changing political landscape, corporations will need leaders who can operate in both the political and business world. Hear from our expert panel as they discuss the strategic considerations savvy global businesses will be taking over the coming years.
Speakers from this panel include experts from Albright Stonebridge Group, Control Risks, and Willis Towers Watson. The panel will be moderated by Professor Jonathan Brookfield of The Fletcher School.
Laura is a Senior Vice President for Willis Towers Watson where she specializes in providing political risk insurance expertise to Fortune 1000 corporations, non-profit organizations, and capital markets transactions with investment exposure in emerging markets. With over 14 years of experience as an underwriter and broker, Laura has placed many innovative political risk programs in both the private markets of New York, London and Bermuda as well as public market placements with OPIC and MIGA.
Prior to joining Willis Towers Watson in 2014, she was Vice President of political risk within Marsh's Political Risk practice. Laura began her career in insurance with Chubb, as an underwriter trainee. She then took on various roles as underwriter, senior underwriter, territory manager, and broker. Prior to joining the insurance industry, Laura served as an intern with the U.S. Department of State (formerly the U.S. Information Agency).
Laura obtained her B.A. in Policy Studies from Dickinson College and a M.A. in International Relations from the Fletcher School of Law and Diplomacy, Tufts University.
Anand Shah is a Senior Vice President of ASG’s India and South Asia practice, where he helps clients manage both short-term challenges and long-term growth opportunities. Mr. Shah brings over 15 years of experience working across the private and social sectors and has significant experience building and growing businesses in India.
Before joining ASG, Mr. Shah led global strategy for new ventures at BMW Group on urban impact and autonomous mobility. He also was an Advisor and Manager at Audi AG in the Social Innovation department, where he applied engineering, design, and manufacturing techniques to sustainable, urban innovation.
Mr. Shah founded and served as CEO of Saravajal, a technology and market-based provider of clean water to rural villages and urban settlements in Gujarat, India and he holds several patents in drinking water distribution technologies. In addition, Mr. Shah helped establish Ahmedabad University and has worked extensively in India on policy in higher education, solar energy and urban infrastructure. Mr. Shah was the founding CEO of the Piramal Foundation and a co-founder of Teach for India. He also was a co-founder and Executive Director of Indicorps, a non-profit organization, that connects the Indian diaspora with opportunities to contribute to India’s development.
Mr. Shah also serves as a TED fellow and an Aspen Institute Global Leadership Network fellow. He holds an A.B. in evolutionary biology from Harvard University and studied science, ethics and society at the California Institute of Technology. Mr. Shah is proficient in Hindi and Gujarati. He is based in Washington, D.C.
Jessica is a senior member of Pfizer’s Corporate Strategy Team, based in NYC, where she supports Pfizer’s Senior Leaders, Executive Leadership Team, and Board of Directors. Jessica specializes in long-term risk management and revenue durability. She also works closely with Pfizer’s Policy and Government Affairs, Market Access, and Economics and Finance groups to quantify macroeconomic, political and regulatory pressures and to identify potential upsides and opportunities.
Before focusing on strategic planning, Jessica was a member of the Center of Excellence for Strategic Pricing and Reimbursement. She was also the Pricing and Reimbursement Lead for key assets like Lipitor, Aricept and Lyrica, and the European Market Access Lead for Pfizer’s Primary Care portfolio. She developed sustainable and fit-for-purpose pricing and access strategies and coordinated pricing negotiations with institutional, private and government reimbursement authorities.
Prior to Pfizer, Jessica was a consultant with IMS Consulting and LEK Consulting where she advised small and large cap pharma and biotech companies. She is an advisor and active member of various industry associations focused on innovative access and corporate responsibility initiatives, and she has a background in medicine and biomedical research in the fields of virology, neurology, and infectious diseases. Jessica holds a BA in Molecular Biology from Princeton University and is an alumna of Fletcher’s GMAP Program (M.A. in International Affairs).
Dan serves as Principal for Global Risk Analysis based in NYC, specializing in strategic engagements with clients as they evaluate and manage political risk and opportunity. Dan is also an Adjunct Professor at New York University where he is the Program Director for the Advanced Diploma on Political Risk Management, launching Fall 2017.
Prior to Control Risks, Dan was a Director at Eurasia Group, a NYC-based political risk firm, where he managed the firm’s largest client relationships and many key growth initiatives, including corporate executive education in political risk management. For 8 years before that, Dan managed the Americas transaction team at Iridium Partners, a boutique Investment Bank and Private Equity advisory in NYC. Additionally, Dan worked as an Associate in the Corporate Development group of Marsh & McLennan Companies, and has consulted on projects alongside a former Under-Secretary General of the United Nations participating in presidential elections in Uganda, and another with the Business Council for the United Nations, UNA-USA. Dan holds a B.A. in Macro Economics from NYU and an M.S. in International Affairs from the New School.
Jonathan Brookfield, Associate Professor of Strategic Management and International Business, teaches classes on strategic management, international business, the political economy and business environments of greater China, privatization, nationalization, and the boundary between State and private sector, and business groups in Asia. He received a B.S. from Yale, an MPhil from the University of Cambridge, and a PhD from the University of Pennsylvania. Professor Brookfield has published several articles looking at different kinds of business networks in Asia and sits on the editorial review boards of the Asia Pacific Journal of Management and the Journal of International Business Studies. His current research interests include comparative political economy, political risk, business groups, interfirm networks, industrial districts, firm boundaries, and business in Asia.